Merck halts development of HIV drug after decreases in white blood cells in phase 2 trial
November 19 2021 - 6:13AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024